Literature DB >> 30284873

State anxiety predicts cognitive performance in patients with Parkinson's disease.

Kaylena A Ehgoetz Martens1, Carolina R A Silveira1, Brittany N Intzandt1, Quincy J Almeida1.   

Abstract

OBJECTIVE: Anxiety is common in Parkinson's disease (PD) and frequently a comorbidity that appears alongside nonmotor symptoms such as cognitive deficits; however, the relationship between anxiety and cognition in PD remains poorly understood. The aim of this study was to investigate the relationship between anxiety and specific cognitive domains (e.g., attention/working memory, executive functions, memory, language, and visuospatial function).
METHOD: A total of 48 individuals with PD and 18 healthy controls were assessed using the State Trait Anxiety Inventory along with a comprehensive neuropsychological battery. Hierarchical multiple regression analysis was used to examine whether trait and/or state anxiety predicted deficits in overall cognitive function (Montreal Cognitive Assessment) and/or specific individual cognitive domains in the PD and healthy control samples while controlling for covariates such as age, depression (Geriatric Depression Scale), and Unified Parkinson's disease Rating Scale motor-subsection-III (PD only).
RESULTS: Results showed that state anxiety in PD significantly predicted performance across an array of cognitive domains, such as attention/working memory, executive functioning, memory, and language, whereas trait anxiety was a predictor only for executive functioning. In contrast, there was no significant relationship between state anxiety and visuospatial ability Conclusions: Overall, these findings highlight that performance in particular cognitive domains are associated with anxiety in PD. Thus, it may be critically important to consider and quantify the contribution of anxiety to cognitive performance when diagnosing and treating dementia and/or mild cognitive impairments in PD. (PsycINFO Database Record (c) 2018 APA, all rights reserved).

Entities:  

Mesh:

Year:  2018        PMID: 30284873     DOI: 10.1037/neu0000478

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  5 in total

1.  Depressive symptoms precede cognitive impairment in de novo Parkinson's disease patients: Analysis of the PPMI cohort.

Authors:  Jacob D Jones; Natalie E Kurniadi; Taylor P Kuhn; Sarah M Szymkowicz; Joseph Bunch; Elizabeth Rahmani
Journal:  Neuropsychology       Date:  2019-07-25       Impact factor: 3.295

Review 2.  Freezing of gait: understanding the complexity of an enigmatic phenomenon.

Authors:  Daniel Weiss; Anna Schoellmann; Michael D Fox; Nicolaas I Bohnen; Stewart A Factor; Alice Nieuwboer; Mark Hallett; Simon J G Lewis
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

Review 3.  Depression in Patients with Parkinson's Disease: Current Understanding of its Neurobiology and Implications for Treatment.

Authors:  Stéphane Prange; Hélène Klinger; Chloé Laurencin; Teodor Danaila; Stéphane Thobois
Journal:  Drugs Aging       Date:  2022-06-16       Impact factor: 4.271

4.  Acute relationships between mental health and cognitive function during the COVID-19 pandemic: Longitudinal evidence from middle-aged and older US adults.

Authors:  Lindsay C Kobayashi; Brendan Q O'Shea; Carly Joseph; Jessica M Finlay
Journal:  SSM Ment Health       Date:  2022-04-08

5.  The Contribution of Noradrenergic Activity to Anxiety-Induced Freezing of Gait.

Authors:  Natasha L Taylor; Gabriel Wainstein; Dione Quek; Simon J G Lewis; James M Shine; Kaylena A Ehgoetz Martens
Journal:  Mov Disord       Date:  2022-04-05       Impact factor: 9.698

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.